Showing results (1041-1050 of 10,559) with videos related to
Sort By:
Pageof 1,056
Thrombosis Research|October 18, 2022
Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort studyJohn Podstawka, Erika Wall, Lauren Bolster, et al.Thrombosis Research|September 2, 2022
The short-term predictive value of CD4+ cells for combination therapy with high-dose dexamethasone and immunoglobulin in newly diagnosed primary immune thrombocytopenia patientsHongyun Liu, Xiaoyan Liu, Guoyang Zhang, et al.Thrombosis Research|September 3, 2022
Thromboembolic events in deceased patients with proven SARS-CoV-2 infection: Frequency, characteristics and risk factorsMinna Voigtlaender, Carolin Edler, Moritz Gerling, et al.Thrombosis Research|August 15, 1986
Plasma levels of fibrin fragments in men with myocardial infarctionS Rogers, P M Sweetnam, M J Perry, et al.Thrombosis Research|August 15, 1986
Heparin cofactor activity and antithrombin III antigen levels in preeclampsiaK D Friedman, Z Borok, J OwenThrombosis Research|September 15, 1986
Antithrombotic and haemorrhagic effects of synthetic and naturally occurring thrombin inhibitorsB Kaiser, F MarkwardtThrombosis Research|September 15, 1986
The effect of operation and subcutaneous heparin on plasma levels of antithrombin-IIIT Harbourne, A N NicolaidesThrombosis Research|August 15, 1993
The antithrombotic and anticoagulant effects of a synthetic tripeptide and recombinant hirudin in various animal modelsP Bacher, J M Walenga, O Iqbal, et al.Thrombosis Research|August 15, 1993
Thermal stability of low molecular weight urokinase during heat treatment. I. Effects of protein concentration, pH and ionic strengthW R Porter, H Staack, K Brandt, et al.Thrombosis Research|August 15, 1993
The potential role of platelet PAl-1 in t-PA mediated clot lysis of platelet rich plasmaK Serizawa, T Urano, Y Kozima, et al.Pageof 1,056